Our sustainability mission

Use our ground-breaking science to bring health to society while protecting the health of the planet.

Sustainability at AstraZeneca: Making Science Accessible

At AstraZeneca we’re united by our desire to push the boundaries of science. We know it’s how we will continue to transform the lives of 200 million patients around the world while delivering value to our shareholders, our people and our partners.

We want to be valued and trusted by our stakeholders as a source of great medicines over the long-term. We recognise the connection between maintaining a healthy business, making a positive impact on society and protecting the environment, and we are committed to applying our science-based approach to deliver all three. As we develop innovative new medicines to improve the lives of patients around the world, we support global progress on megatrends such as the United Nation’s global sustainable development goals (SDG), notably SDG3 for Good Health.


What sustainability means to us

As a global biopharmaceutical company, we emphasize our first pillar of sustainability: improving access to healthcare. This is where we feel we can make the biggest difference. AstraZeneca has a critical role to play in the challenge of sustainable health. Non-communicable diseases (NCDs) are now the leading cause of death worldwide. Our focus on three main therapy areas of chronic disease – oncology, cardiovascular & metabolic disease and respiratory – means that our portfolio is well-placed to make a positive impact on this global challenge.

2017 Highlights

Access to Healthcare

Environmental Protection

Ethics & Transparency

5.7 million

patients accessed hypertension education, screening and treatment through Healthy Heart Africa


of our power is sourced from renewable sources


of active employees trained in code of ethics


patients accessed hypertension education, screening and treatment through Healthy Heart Africa

CDP A lists

on the CPD Climate A list and Water A list, for the second year running, for our actions and disclosures on climate change and water stewardship


Patient Partnership Programme

9.0 million

patients benefited from patient access programmes

Reduced by 7%

our operational greenhouse gas (GHG) footprint against our 2015 baseline

€6.9 million

worth of counterfeit and illegal medicines seized

Our three sustainability priorities

Read more about our community investments here.